ArticleCureus2025
Spontaneous Bilateral Drusen Regression Without Atrophy in an Octogenarian With Gilbert's Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We document significant drusen regression without atrophy (DRwoA) in a patient with dry age-related macular degeneration (AMD) and concomitant hyperbilirubinemia. Serial optical coherence tomography (OCT) and fundus images were used to monitor drusen progression in the patient. Fundus photography of the macula revealed a dramatic improvement in visible drusen in each eye over the course of 2020-2023. Only a few small drusen were visible in the right eye, while moderate to intermediate-to-large soft drusen were present in the left eye. OCT imaging also demonstrated significant improvement in drusen in both eyes compared to previous years. Average foveal thickness measurements from 2018 to 2023 showed a significant and steady decline, from 298 µm to 291 µm in the right eye and from 305 µm to 273 µm in the left eye. We report significant drusen regression in a patient with Gilbert's syndrome and dry AMD. Further investigation into the prevalence and severity of AMD in patients with Gilbert's syndrome is warranted. Additionally, further study of the potential therapeutic application of Spirulina in treating inflammatory conditions such as AMD is reasonable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.